Sartorius is collaborating with Sanofi to develop an end-to-end platform for integrated and continuous downstream bioprocessing (ICB). Sartorius will contribute its engineering and manufacturing ...
Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.
Sartorius launches a premier industry event focused on process intensification (PI) for protein therapeutics and emerging modalities. Forum features expert-led sessions, hands-on workshops, and live ...
Acquisition aims to strengthen company’s downstream process offering of advanced filtration and chromatography solutions JSR’s innovative Amsphere™ Protein A resin technology complements the company’s ...
Despite the importance of downstream bioprocessing, there are many opportunities for improvement, according to a report by Alois Jungbauer, PhD, a retired professor of biotechnology at the University ...
Drug Substance manufacturing is a critical component of pharmaceutical production, requiring precise processes, rigorous quality control, and innovative solutions to overcome various challenges. From ...
What is Pharma 4.0? The term Industry 4.0 refers to the fourth industrial revolution, associated with the application of advanced technologies that have dramatically changed the landscape of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback